Telavant
Company, is developing innovative therapies to.
Employees
Enterprise value
$7.1b
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Corporate spinout | ||
* | $7.1b Valuation: $7.1b | Acquisition | |
| Total Funding | - | ||
Roivant Sciences(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads